Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expectant versus active management with sublingual misoprostol for term premature rupture of membranes
PACTR202206797734088Completed
- Sponsor
- The Principal investigator Dr Awkadigwe Fredrick Ikenna
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of misoprostol in Rupture of amniotic membranes (PROM), sponsored by The Principal investigator Dr Awkadigwe Fredrick Ikenna. Started Jun 2022; status: completed.
02
Drugs
misoprostol
03
Conditions
Rupture of amniotic membranes (PROM)
Beyond the preview
Go deeper on PACTR202206797734088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202206797734088.